Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification.

about

Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification.

Item

http://www.wikidata.org/entity/Q47933145

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Glioma targeted delivery strat ...... s by dual-ligand modification.

@en

Glioma targeted delivery strat ...... s by dual-ligand modification.

@nl

type

Item

label

Glioma targeted delivery strat ...... s by dual-ligand modification.

@en

Glioma targeted delivery strat ...... s by dual-ligand modification.

@nl

prefLabel

Glioma targeted delivery strat ...... s by dual-ligand modification.

@en

Glioma targeted delivery strat ...... s by dual-ligand modification.

@nl

P1476

Glioma targeted delivery strat ...... s by dual-ligand modification.

@en

P2093

Guangfu Yin

http://www.w3.org/2001/XMLSchema#string

Wei Han

http://www.w3.org/2001/XMLSchema#string

Xianchun Chen

http://www.w3.org/2001/XMLSchema#string

Xiaoming Liao

http://www.w3.org/2001/XMLSchema#string

Ximing Pu

http://www.w3.org/2001/XMLSchema#string

Zhongbing Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Progress and perspectives on targeting nanoparticles for brain drug delivery.

Progress on the diagnosis and evaluation of brain tumors.

Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity.

Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

Increased delivery of TAT across an endothelial monolayer following ischemic injury.

Angiogenesis in brain tumours.

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

Trigger release liposome systems: local and remote controlled delivery?

Liposomal drug delivery systems: from concept to clinical applications.

P304

1695-1712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09205063.2017.1348739

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28699828

http://www.w3.org/2001/XMLSchema#string